Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | AXL | P30530 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19721400 | 0.81 | KDM4E (0.42) | KDM4EALDH1A1PIK3CAMAPT | |
| SCHEMBL21315933 | 0.78 | ALDH1A1 (0.36) | KDM4EALDH1A1GAAMAPTHPGD | |
| SCHEMBL26276546 | 0.72 | KDM4E (0.35) | KDM4EALDH1A1 | |
| SCHEMBL23096212 | 0.70 | KDM4E (0.41) | KDM4EALDH1A1PIK3CAMAPT | |
| SCHEMBL21315928 | 0.70 | TDO2 (0.35) | AXL | |
| SCHEMBL21315930 | 0.70 | AXL (0.31) | AXL | |
| SCHEMBL19255753 | 0.69 | KDM4E (0.37) | KDM4EALDH1A1MAPT | |
| SCHEMBL11884983 | 0.67 | KDM4E (0.55) | KDM4EALDH1A1PIK3CAGAAMAPT | |
| SCHEMBL21315919 | 0.66 | LIMK1 (0.35) | KDM4EALDH1A1PIK3CAHPGD | |
| SCHEMBL23946597 | 0.64 | KDM4E (0.53) | KDM4EALDH1A1PIK3CAGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10403826-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403826-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | KDM4E 2289/4885ALDH1A1 1283/4885PIK3CA 3189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.